Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Vildan Kayku Liv Hospital Bahçeşehir Spec. MD. Vildan Kayku Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Types of Chemotherapy Drugs: 7 Key Types
Types of Chemotherapy Drugs: 7 Key Types 4

Choosing the right chemotherapy treatment is key for effective cancer care. At Liv Hospital, we focus on our patients, giving them access to the safest and most advanced treatments.

Chemotherapy uses medicines to kill cancer cells. There are many chemotherapy treatment types, each working differently.

We will look at the seven main types ofchemotherapydrugs. We’ll cover what each type does, how it works, and give examples. Knowing about these types helps both patients and doctors make better treatment choices. Types of chemotherapy drugs: 7 major types explained with common examples.

Key Takeaways

  • Chemotherapy drugs are sorted by how they work and the cancers they treat.
  • There are seven main types of chemotherapy drugs.
  • Each type has its own features and uses in fighting cancer.
  • It’s important to understand the different chemotherapy types for effective treatment.
  • Liv Hospital offers the safest and most advanced chemotherapy treatments.

The Science Behind Chemotherapy in Cancer Treatment

Types of Chemotherapy Drugs: 7 Key Types
Types of Chemotherapy Drugs: 7 Key Types 5

Understanding chemotherapy is key to seeing its role in fighting cancer. It targets cells that grow fast, a trait of cancer cells. This treatment uses drugs to kill cancer cells all over the body.

How Chemotherapy Targets Rapidly Dividing Cells

Chemotherapy drugs aim at cells that are dividing quickly. Cancer cells grow fast, so chemotherapy hits them hard. It works by targeting cells at different stages of division, making it effective against many cancers.

For example, alkylating agents damage cancer cells’ DNA, stopping them from growing. Antimetabolites block DNA and RNA production, needed for cell growth.

Systemic vs. Regional Administration Methods

Chemotherapy can be given in two ways: systemically or regionally. Systemic treatment goes into the bloodstream to reach cancer cells everywhere. It’s used when cancer has spread or might spread. Regional treatment delivers drugs directly to the cancer site, like through arteries or the abdomen.

  • Systemic chemotherapy is good for cancers that have spread or might spread.
  • Regional chemotherapy is best for cancers in one area.

Goals of Chemotherapy: Curative, Adjuvant, and Palliative

Chemotherapy’s goals change based on the cancer type, stage, and patient’s health. It can aim to cure cancer, be used after other treatments to prevent return, or focus on easing symptoms and improving life quality.

Types of Chemotherapy Drugs and Their Classification

Types of Chemotherapy Drugs: 7 Key Types
Types of Chemotherapy Drugs: 7 Key Types 6

It’s important to know the different types of chemotherapy drugs for effective cancer treatment. Chemotherapy is a key part of treating many cancers. Drugs are sorted by how they work, their chemical makeup, and the cancer they target.

How Oncologists Select Appropriate Chemotherapy Agents

Oncologists pick chemotherapy drugs based on several factors. They look at the cancer type, its stage, and the patient’s health. They aim to find a treatment that works well but is not too harsh.

They also think about the patient’s past treatments, any drug interactions, and health issues. This tailored approach helps get the best results.

Cell Cycle-Specific vs. Non-Specific Mechanisms

Chemotherapy drugs are divided into cell cycle-specific and non-specific types. Specific drugs target cells in certain phases of the cell cycle. Non-specific drugs affect cells in all phases.

For example, antimetabolites block DNA synthesis in the S phase. Alkylating agents, on the other hand, damage DNA in all cell cycle phases.

The Evolution of Chemotherapy Drug Development

Chemotherapy drug development has changed a lot over time. Now, we focus on making drugs that are more precise and less harmful. New discoveries in molecular biology have helped find targets for chemotherapy. This has led to drugs that are more specific to cancer cells.

Chemotherapy ClassMechanism of ActionExamples
Alkylating AgentsDNA cross-linkingCyclophosphamide, Cisplatin
AntimetabolitesInhibiting DNA synthesisMethotrexate, 5-Fluorouracil
Plant AlkaloidsMitotic inhibitionVincristine, Paclitaxel

Understanding these classifications helps doctors create treatment plans that fit each patient’s needs. This improves cancer care outcomes.

Alkylating Agents: The Cornerstone of Chemotherapy

Alkylating agents are key in chemotherapy, helping to fight cancer for decades. They target cancer cells’ DNA, stopping them from making copies of themselves.

Mechanism: DNA Cross-Linking and Cell Cycle Disruption

These agents form bonds with cancer cells’ DNA, causing damage. This damage stops the cells from making more copies. As a result, these cells die, helping to fight cancer. The ability to alkylate DNA is what makes these drugs effective against fast-growing cancer cells.

Effectiveness Against Slow-Growing Solid Tumors

Alkylating agents are also good at fighting slow-growing tumors. They can target cancer cells that aren’t growing fast. This makes them useful for treating tumors that grow slowly.

Common Examples: Cyclophosphamide, Cisplatin, and Busulfan

Examples of alkylating agents include cyclophosphamide, cisplatin, and busulfan. These drugs are used in many cancer treatments. For example, cyclophosphamide is used with other drugs for lymphomas and leukemias. Cisplatin is often used for testicular, ovarian, and bladder cancers.

Understanding alkylating agents and their role in chemotherapy is important. They are a key part of many treatments, helping patients with different cancers.

Nitrosoureas: Specialized Agents for Brain Tumors

Nitrosoureas have changed how we treat brain tumors. These chemotherapy drugs can get past the blood-brain barrier. This is key for fighting cancers in the central nervous system.

Blood-Brain Barrier Penetration Capabilities

Nitrosoureas can get into the brain because they are fat-loving. This is important because many drugs can’t get past the blood-brain barrier.

Key Features of Nitrosoureas:

  • Lipophilicity allowing blood-brain barrier penetration
  • Alkylating mechanism of action
  • Effective against certain CNS malignancies

Applications in Glioblastoma and Other CNS Malignancies

Nitrosoureas are very good at fighting glioblastoma, a tough brain cancer. They can get into the brain, making them a big part of treatment plans for brain cancers.

Clinical Evidence: Research shows nitrosoureas help patients with glioblastoma and other brain cancers live longer.

Common Examples: Carmustine (BCNU) and Lomustine (CCNU)

Carmustine (BCNU) and lomustine (CCNU) are often used in treatment. They help with glioblastoma and medulloblastoma, among other brain tumors.

NitrosoureaCommon UseNotable Characteristics
Carmustine (BCNU)Glioblastoma, Hodgkin’s lymphomaHighly lipophilic, crosses blood-brain barrier
Lomustine (CCNU)Brain tumors, Hodgkin’s lymphomaOral administration, myelosuppressive

Antimetabolites: Blocking Cancer Cell DNA Synthesis

Antimetabolites are key drugs in chemotherapy that stop cancer cells from making DNA. They look like natural parts of cells but don’t work right. This stops cancer cells from growing.

Mechanism: Mimicking Natural Metabolites to Disrupt Replication

Antimetabolites pretend to be DNA or RNA parts. They get mixed into the DNA-making process. This messes up cell growth, causing cancer cells to die.

Methotrexate blocks an enzyme needed for DNA, and 5-fluorouracil messes with another important enzyme. This stops cancer cells from making more DNA.

Applications in Leukemias, Lymphomas, and Solid Tumors

Antimetabolites help treat many cancers, like leukemias, lymphomas, and some solid tumors. They work well because they stop fast-growing cells, which is common in cancer. For example, cytarabine is key in treating leukemia, and methotrexate helps with lymphomas and some solid tumors.

Common Examples: Methotrexate, 5-Fluorouracil, and Cytarabine

The table below shows some common antimetabolites, how they work, and where they’re used:

AntimetaboliteMechanismPrimary Applications
MethotrexateInhibits dihydrofolate reductaseLeukemias, lymphomas, breast cancer
5-FluorouracilInhibits thymidylate synthaseColorectal cancer, breast cancer
CytarabineIncorporates into DNA, inhibiting replicationAcute myeloid leukemia

Understanding how antimetabolites work helps us see their importance in cancer treatment. These drugs are a big part of fighting cancer, giving hope and better chances for survival to many patients.

Plant Alkaloids and Natural Products: Mitotic Inhibitors

Plant alkaloids and natural products are key in fighting cancer. They come from plants and other natural sources. These compounds stop cancer cells from growing by blocking cell division.

Disrupting Cell Division Through Tubulin Interaction

These agents work by affecting tubulin, a protein needed for cell division. They either make microtubules stable or unstable. This stops cancer cells from growing. For example, vinca alkaloids like vincristine and vinblastine stop microtubule assembly, halting cell division.

Applications in Breast, Lung, and Hematologic Cancers

These drugs help treat many cancers, including breast, lung, and blood cancers. For instance, paclitaxel, from the Pacific yew tree, is used for breast and ovarian cancers. Vinca alkaloids are also used for blood cancers.

Common Examples: Vincristine, Paclitaxel, and Vinblastine

Vincristine, paclitaxel, and vinblastine are well-known for their use in cancer treatment. They are part of many chemotherapy plans. Below is a table showing how they work and where they are used.

DrugMechanismCommon Applications
VincristineBinds to tubulin, preventing microtubule assemblyLymphomas, Leukemias
PaclitaxelStabilizes microtubules, preventing cell divisionBreast, Ovarian Cancers
VinblastineBinds to tubulin, preventing microtubule assemblyLymphomas, Testicular Cancer

In summary, plant alkaloids and natural products are essential in cancer treatment. They work by stopping cell division through tubulin interaction.

Antitumor Antibiotics: Microorganism-Derived Agents

Antitumor antibiotics are important drugs made from microorganisms. They help fight cancer by messing with the DNA of cancer cells.

DNA Intercalation and Free Radical Generation Mechanisms

These drugs work in two main ways. They either get in between DNA base pairs or create free radicals. Getting in between DNA base pairs stops DNA from working right, causing cell death. Free radicals damage DNA, which also kills cancer cells.

Mechanism of Action: By getting in between DNA, these drugs stop DNA from unwinding. This is needed for DNA to copy itself. Without it, cancer cells can’t grow.

Broad-Spectrum Activity Against Multiple Cancer Types

Antitumor antibiotics are good against many cancers. They treat leukemias, lymphomas, and solid tumors. Their wide use makes them key in many treatments.

Cancer TypeCommon Antitumor Antibiotics Used
LeukemiaDoxorubicin, Dactinomycin
LymphomaBleomycin, Doxorubicin
Solid TumorsDactinomycin, Doxorubicin

Common Examples: Doxorubicin, Bleomycin, and Dactinomycin

Doxorubicin, bleomycin, and dactinomycin are well-known. Doxorubicin fights breast cancer, lymphomas, and leukemias. Bleomycin works on testicular cancer and Hodgkin’s lymphoma. Dactinomycin treats Wilms’ tumor, rhabdomyosarcoma, and Ewing’s sarcoma.

These drugs have greatly helped cancer patients. They are a big part of chemotherapy today.

Topoisomerase Inhibitors: Targeting DNA Repair Enzymes

Topoisomerase inhibitors are key drugs in chemotherapy that target DNA repair in cancer cells. They are vital in stopping cancer cells from growing by blocking enzymes needed for DNA replication and repair.

Mechanism: Preventing DNA Unwinding and Religation

These drugs block topoisomerase enzymes, which are key for DNA unwinding and replication. There are two main types: Type I and Type II. Type I relaxes DNA by creating single-strand breaks. Type II fixes tangles by making double-strand breaks. By stopping these enzymes, the drugs prevent cancer cells from copying their DNA, leading to cell death.

The drugs work by keeping the topoisomerase-DNA complex stable. This stops DNA strands from rejoining. This leads to DNA damage, causing cancer cells to stop growing and die.

Applications in Ovarian, Lung, and Pediatric Cancers

Topoisomerase inhibitors are effective against many cancers, like ovarian, lung, and pediatric cancers. In ovarian cancer, they’re used in combination to improve treatment results. In lung cancer, they work against both small cell and non-small cell types.

In kids with cancer, these drugs are used to treat leukemia and solid tumors. They cause DNA damage and trigger cell death, making them key in treating aggressive cancers in children.

Common Examples: Etoposide, Irinotecan, and Topotecan

Drugs like etoposide, irinotecan, and topotecan are used in treatment. Etoposide is a Type II inhibitor for testicular, lung, and lymphoma cancers. Irinotecan, a Type I inhibitor, is mainly for colorectal cancer. Topotecan, also a Type I inhibitor, is used for ovarian and small cell lung cancers.

DrugTopoisomerase TypePrimary Indications
EtoposideType IITesticular cancer, lung cancer, lymphoma
IrinotecanType IColorectal cancer
TopotecanType IOvarian cancer, small cell lung cancer

Modern Combination Approaches and Treatment Protocols

Cancer treatment is getting better, thanks to combination chemotherapy. Now, doctors mix different drugs and treatments to fight cancer cells better.

Rationale for Multi-Drug Chemotherapy Regimens

Combination chemotherapy aims to hit cancer cells from all sides. This makes it harder for cancer to resist treatment. By mixing drugs that work in different ways, we can tackle cancer’s many faces.

Common Combination Protocols by Cancer Type

The right mix of drugs depends on the cancer type, its stage, and the patient’s health. For example, in breast cancer, doctors often use AC-T. In colorectal cancer, FOLFOX is a common choice.

Cancer TypeCommon Combination Protocols
Breast CancerAC-T (Adriamycin, Cyclophosphamide, Taxotere)
Colorectal CancerFOLFOX (5-Fluorouracil, Leucovorin, Oxaliplatin)
LymphomaR-CHOP (Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone)

Integration with Targeted Therapies and Immunotherapy

Chemotherapy is now paired with targeted and immunotherapy treatments. This combo aims to boost treatment success. Targeted therapies, like trastuzumab, and immunotherapies, like checkpoint inhibitors, are used alongside traditional chemotherapy.

Conclusion: The Evolving Landscape of Chemotherapy in Cancer Care

We’ve looked at the wide range of chemotherapy drugs and their key role in fighting cancer. It’s important to know about the different types of chemotherapy drugs. These include alkylating agents, antimetabolites, plant alkaloids, antitumor antibiotics, and topoisomerase inhibitors.

These drugs are sorted by how they work and the cancers they treat. This helps doctors choose the best treatment for each patient.

As cancer research grows, so does the development of new chemotherapy drugs and treatments. We’re moving towards treatments that target cancer more precisely. This means combining chemotherapy with other treatments like immunotherapy.

The goal is to make treatments more effective and have fewer side effects. This could lead to better results for patients.

In summary, chemotherapy is a vital part of cancer treatment. Its many types and classifications give us powerful tools to fight cancer. As we keep exploring new ways to treat cancer, chemotherapy will play an even bigger role. This brings hope to patients all over the world.

FAQ

What are the main categories of chemotherapy drugs?

Chemotherapy drugs are divided into seven main types. These include alkylating agents, nitrosoureas, antimetabolites, and plant alkaloids. There are also antitumor antibiotics, topoisomerase inhibitors, and other agents.

How do alkylating agents work in chemotherapy?

Alkylating agents add groups to DNA, causing it to break down. This stops cancer cells from growing and eventually kills them. They work best on slow-growing tumors.

What makes nitrosoureas unique in chemotherapy?

Nitrosoureas can get past the blood-brain barrier. This makes them great for treating brain cancers like glioblastoma.

How do antimetabolites disrupt cancer cell growth?

Antimetabolites act like DNA or RNA parts. They stop cancer cells from making new DNA, which is key for their growth.

What is the role of plant alkaloids in chemotherapy?

Plant alkaloids and natural products mess with cell division. They either help or hinder the formation of microtubules, stopping cancer cells from growing.

How do antitumor antibiotics exert their effects?

Antitumor antibiotics damage DNA by intercalating into it or making free radicals. This causes DNA damage and kills cancer cells.

What is the mechanism of action of topoisomerase inhibitors?

Topoisomerase inhibitors block the enzyme topoisomerase. This enzyme is vital for DNA replication and repair. Without it, cancer cells can’t replicate and die.

Why are combination chemotherapy regimens used?

Using multiple drugs together helps fight drug resistance. It also boosts treatment success by attacking cancer cells in different ways.

How are chemotherapy drugs classified?

Chemotherapy drugs are sorted by how they work, the cancers they treat, and their chemical makeup.

What is the difference between cell cycle-specific and non-specific chemotherapy drugs?

Cell cycle-specific drugs target cells in certain phases of growth. Non-specific drugs work on cells in any phase.

How has the development of chemotherapy drugs evolved?

Chemotherapy drug development has grown a lot. New drugs target specific cancer cell mechanisms, leading to better treatment results.

References

  1. Kaye, S. B. (1998). New antimetabolites in cancer chemotherapy and their clinical impact. Cancer Research Campaign Department of Medical Oncology.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062805/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Vildan Kayku Medical Oncology

Spec. MD. Vildan Kayku

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 28 17